Shots: Ironwood to receive three non-contingent payment of $35M b/w 2021 & 2024, ~$90M as a milestone with royalties on sales of Linzess in China mainland, China Hong Kong and […]readmore
Tags : (linaclotide)
Shots: The P-IIIb study results involve assessing of Inzess (290 mcg, qd) vs PBO in 614 adult patients on multiple abdominal symptoms with IBS-C The P-III study results met its […]readmore
Shots: The approval is based on P-III study results assessing Linzess (290 mcg) vs PBO in 839 patients in ratio the (1:1) with IBS-C in adults for 12 weeks The […]readmore